Trademark: 90447045
Status Date
Tuesday, July 11, 2023
Registration Number
7108424
Registration Date
Tuesday, July 11, 2023
Filing Date
Monday, January 4, 2021
Published for Opposition
Tuesday, September 13, 2022
5 Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use
Jul 11, 2023
Notice Of Registration Confirmation Emailed
Jul 11, 2023
Registered-Principal Register
Jun 9, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 8, 2023
Allowed Principal Register - Sou Accepted
Jun 6, 2023
Statement Of Use Processing Complete
May 15, 2023
Use Amendment Filed
Jun 6, 2023
Case Assigned To Intent To Use Paralegal
May 15, 2023
Teas Statement Of Use Received
May 4, 2023
Notice Of Approval Of Extension Request E-Mailed
May 2, 2023
Sou Extension 1 Granted
May 2, 2023
Sou Extension 1 Filed
May 2, 2023
Teas Extension Received
Nov 8, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 13, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 13, 2022
Published For Opposition
Aug 24, 2022
Notification Of Notice Of Publication E-Mailed
Aug 6, 2022
Approved For Pub - Principal Register
Jul 8, 2022
Teas/Email Correspondence Entered
Jul 8, 2022
Correspondence Received In Law Office
Jul 8, 2022
Teas Response To Office Action Received
Jan 10, 2022
Notification Of Non-Final Action E-Mailed
Jan 10, 2022
Non-Final Action E-Mailed
Jan 10, 2022
Non-Final Action Written
Jul 22, 2021
Notification Of Non-Final Action E-Mailed
Jul 22, 2021
Non-Final Action E-Mailed
Jul 22, 2021
Non-Final Action Written
Jul 12, 2021
Assigned To Examiner
Apr 2, 2021
New Application Office Supplied Data Entered
Jan 7, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
